Randomized phase II study comparing cisplatin plus pemetrexed plus bevacizumab with carboplatin plus paclitaxel plus bevacizumab in treatment-naive advanced non-squamous non-small cell lung cancer (CLEAR study)

被引：0

作者：

Koyama, R. ^{[1
]}

Udagawa, H. ^{[2
]}

Sugiyama, E. ^{[3
]}

Komuta, K. ^{[4
]}

Mori, M. ^{[5
]}

Yokoyama, T. ^{[6
]}

Sasaki, T. ^{[7
]}

Saito, H. ^{[8
]}

Ishida, H. ^{[9
]}

Nakagawa, H. ^{[10
]}

Sekine, A. ^{[11
]}

Tamura, A. ^{[12
]}

Shingyoji, M. ^{[13
]}

Mizuno, K. ^{[14
]}

Nakamura, A. ^{[15
]}

Kinoshita, A. ^{[16
]}

Yamanaka, T. ^{[17
]}

Goto, K. ^{[2
]}

机构：

[1] Juntendo Univ, Fac Med, Dept Resp Med, Tokyo, Japan

[2] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan

[3] Natl Canc Ctr, Div Canc Immunol, Kashiwa, Chiba, Japan

[4] Osaka Police Hosp, Dept Resp Med, Osaka, Japan

[5] Natl Hosp Org Toneyama Natl Hosp, Dept Thorac Oncol, Toyonaka, Osaka, Japan

[6] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan

[7] Asahikawa Med Univ, Resp Ctr, Asahikawa, Hokkaido, Japan

[8] Kanagawa Canc Ctr, Dept Thorac Oncol, Yokohama, Kanagawa, Japan

[9] Showa Univ, Div Med Oncol, Sch Med, Tokyo, Japan

[10] Natl Hosp Org Hirosaki Hosp, Dept Resp Med, Hirosaki, Aomori, Japan

[11] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan

[12] Natl Hosp Org Tokyo Natl Hosp, Ctr Pulm Dis, Tokyo, Japan

[13] Chiba Canc Ctr, Div Respirol, Chiba, Japan

[14] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, Kagoshima, Japan

[15] Sendai Kousei Hosp, Dept Pulm Med, Sendai, Miyagi, Japan

[16] Nagasaki Prefecture Shimabara Hosp, Dept Resp Med, Shimabara, Japan

[17] Yokohama City Univ Med, Dept Biostat, Yokohama, Kanagawa, Japan

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1436P

引用

页数：1

共 50 条

[1] A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
Yoshida, Hironori
Kim, Young Hak
Sakamori, Yuichi
Nagai, Hiroki
Ozasa, Hiroaki
Kaneda, Toshihiko
Yoshioka, Hiroshige
Nakagawa, Hiroaki
Tomii, Keisuke
Okada, Asuka
Yoshimura, Kenichi
Hirabayashi, Masataka
Hirai, Toyohiro
[J]. ANTICANCER RESEARCH, 2020, 40 (05) : 2981 - 2987
[2] Multicenter phase II study of cisplatin, pemetrexed, plus bevacizumab followed by maintenance pemetrexed plus bevacizumab for patients with advanced or recurrent non-squamous non-small cell lung cancer: MAP study
Tsutani, Y.
Miyata, Y.
Masuda, T.
Fujitaka, K.
Doi, M.
Awaya, Y.
Kuyama, S.
Kitaguchi, S.
Ueda, K.
Okada, M.
[J]. ANNALS OF ONCOLOGY, 2017, 28 : 137 - 137
[3] A phase II study of oxaliplatin and pemetrexed plus bevacizumab in advanced non-squamous non-small cell lung cancer
Waples, J. M.
Auerbach, M.
Boccia, R.
Wiggans, R. G.
Steis, R.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[4] Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer
Yokoi, Takashi
Torii, Yoshitaro
Katashiba, Yuichi
Sugimoto, Hiroyuki
Tanijiri, Tsutomu
Ogata, Makoto
Inagaki, Noriko
Kibata, Kayoko
Hayashi, Mina
Niki, Maiko
Shimizu, Toshiki
Miyara, Takayuki
Kurata, Takayasu
Nomura, Shosaku
[J]. ONCOLOGY LETTERS, 2014, 8 (06) : 2453 - 2457
[5] RANDOMIZED PHASE II STUDY OF PEMETREXED PLUS CARBOPLATIN FOLLOWED BY PEMETREXED VERSUS PACLITAXEL PLUS CARBOPLATIN FOLLOWED BY PEMETREXED IN ADVANCED NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (LOGIK 0904)
Shiraishi, Yoshimasa
Inoue, Koji
Takeshita, Masafumi
Harada, Taishi
Tashiro, Naoki
Seto, Takashi
Imanaga, Tomotoshi
Fujimoto, Noriko
Nakagaki, Noriaki
Kawasaki, Masayuki
Kishimoto, Junji
Takayama, Koichi
Ichinose, Yukito
[J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S403 - S404
[6] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
Patel, J. D.
Hensing, T. A.
Villafor, V.
Hart, E.
Bonomi, P.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[7] Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab for Japanese nonsquamous non-small cell lung cancer
Yokoi, Takashi
Torii, Yoshitaro
Katashiba, Yuichi
Sugimoto, Hiroyuki
Hayashi, Mina
Shimizu, Toshiki
Nomura, Shosaku
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[8] An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung Cancer
Kaira, Kyoichi
Imai, Hisao
Souma, Ryousuke
Sakurai, Reiko
Miura, Yosuke
Sunaga, Noriaki
Kasahara, Norimitsu
Tsukagoshi, Yusuke
Koga, Yasuhiko
Kitahara, Shinsuke
Kotake, Mie
Minato, Koichi
Naruse, Ichiro
Fukushima, Yasutsugu
Hisada, Takeshi
Ishizuka, Tamotsu
[J]. ANTICANCER RESEARCH, 2019, 39 (05) : 2483 - 2491
[9] Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion
Tamiya, Motohiro
Tamiya, Akihiro
Suzuki, Hidekazu
Taniguchi, Yoshihiko
Katayama, Kanako
Minomo, Shojiro
Nakao, Keiko
Takeuchi, Naoko
Matsuda, Yoshinobu
Naito, Yujiro
Shiroyama, Takayuki
Okamoto, Norio
Okishio, Kyoichi
Kumagai, Toru
Atagi, Shinji
Imamura, Fumio
Hirashima, Tomonori
[J]. INVESTIGATIONAL NEW DRUGS, 2021, 39 (04) : 1106 - 1112
[10] Pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for advanced non-squamous non-small cell lung cancer (NSCLC)
Patel, J. D.
Hensing, T. A.
Rademaker, F.
Hart, E.
Obasaju, C. K.
Treat, J.
Milton, D.
Bonomi, P. D.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →